Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Cotellic®(cobimetinib) – New orphan indication
October 28, 2022 - The FDA approved Genentech’s Cotellic (cobimetinib), as a single agent, for the treatment of adult patients with histiocytic neoplasms.
